CHICAGO, Sept. 13, 2021 /PRNewswire/ -- The immunoglobulins market is expected to grow at a CAGR of 8.01% during the period 2020−2026.
Key Highlights Offered in the Report:
Immunoglobulins market holds major share in the targeted protein therapeutics market.
Developments in plasma fractionation process and recent regulatory approvals are expected to boost the market during the forecast period.
In product type, IVIG holds major market share of around 82.20%, however SCIG is expected to grow with fastest CAGR of 11.11%.
PID holds major share and is expected to dominate the market during with forecast period with an incremental growth of USD 1.85 billion.
Due to the shifting preferences from hospital to home administration in end user segment homecare is anticipated to be the fastest growing segment with an incremental growth of USD 2.13 billion and a CAGR of 10.05%.
North America region is dominating the global immunoglobulins market and is likely to witness highest incremental growth of USD 3.03 billion and APAC is expected to witness highest absolute growth of over 79.35% during the forecast period.
Market Size & Forecast by Revenue | 2020−2026
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by products type, application, end-user, and geography
Competitive Landscape – 5 key vendors and 8 other vendors
Intravenous immunoglobulins or IVIG is the most used form of immunoglobulin for the management of autoimmune diseases and immunodeficiency. The global intravenous immunoglobulins market is expected to reach USD 17.05 billion by 2026.
With the growing developments in the global immunoglobulins market, the intramuscular immunoglobulins segment is expected to witness several new entrants, thereby boosting the market growth.
Western regions such as North America, Latin America, and Western Europe witnessed the highest prevalence of primary immunodeficiency. The global primary immunodeficiency immunoglobulins market growing at a CAGR of 7.26% during the period.
In 2020, the global hospitals and clinics immunoglobulins market was valued at USD 10.85. The hospitals and clinics segment includes the revenue generated from immunoglobulin formulations in hospital, clinic, and inpatient settings. The global hospitals and clinics immunoglobulins market was valued at USD 10.85 billion.
Immunoglobulins Market Segmentation by Products Type
Immunoglobulins Market Segmentation by Application
Chronic Immune Deficiency Polyradiculoneuropathy
Immune Thrombocytopenic Purpura
Immunoglobulins Market Segmentation by End-User
Hospitals & Clinics
Immunoglobulins Market – Dynamics
The immunoglobulins market is growing at a rapid rate due to the increasing prevalence of autoimmune diseases cases and the development in diagnosing technologies. Partnerships with official plasma collection agencies have propelled the growth of many vendors. Many new vendors entering to the market have benefitted from such partnerships. Increasing development of new launches and approvals for immunoglobulins beyond PIDs are expected to fuel the growth of the immunoglobulins market during the forecast period. With the increasing demand for immunoglobulin products across the globe, the plasma fractionation industry is looking for such methods that will offer improved productivity and IgG recovery while keeping wastage at a minimum.
Key Drivers and Trends fueling Market Growth:
Developments in Plasma Fractionation Process
Rising Adoption of Immunoglobulins in Homecare
High Usage of IVIG During Transplant
Self-Sufficiency Programs for Plasma-Derived Medicinal Products
Immunoglobulins Market – Geography
North America has been leading the plasma-derived medicinal products market that includes products such as immunoglobulins and albumins. The US and Canada both have the highest volume of consumption of IVIG products. Immunoglobulins market in North America is a mature market. The US provides almost 71% of the global source plasma, which is much higher than any country across the globe. In 2020, US was a leading country in the global immunoglobulins market, with a 41.50% market share across the region. The immunoglobulins market in the US will grow at a CAGR of 6.84% in the upcoming years.
Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.